BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17270149)

  • 1. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells.
    Fukada K; Takahashi-Yanaga F; Sakoguchi-Okada N; Shiraishi F; Miwa Y; Morimoto S; Sasaguri T
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1166-71. PubMed ID: 17466271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin.
    Torres VA; Tapia JC; Rodríguez DA; Párraga M; Lisboa P; Montoya M; Leyton L; Quest AF
    J Cell Sci; 2006 May; 119(Pt 9):1812-23. PubMed ID: 16608879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
    Kardosh A; Soriano N; Pyrko P; Liu YT; Jabbour M; Hofman FM; Schönthal AH
    J Biomed Sci; 2007 Sep; 14(5):647-62. PubMed ID: 17440835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
    Dihlmann S; Siermann A; von Knebel Doeberitz M
    Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
    Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
    Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.
    Kapitanović S; Cacev T; Antica M; Kralj M; Cavrić G; Pavelić K; Spaventi R
    Exp Mol Pathol; 2006 Feb; 80(1):91-6. PubMed ID: 15963497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
    Kim SH; Hwang CI; Juhnn YS; Lee JH; Park WY; Song YS
    Carcinogenesis; 2007 Jan; 28(1):223-31. PubMed ID: 17166886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of survivin isoforms in the chemopreventive actions of NSAIDS on colon cancer cells.
    Mandayam S; Huang R; Tarnawski AS; Chiou SK
    Apoptosis; 2007 Jun; 12(6):1109-16. PubMed ID: 17151952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway.
    Tang FY; Shih CJ; Cheng LH; Ho HJ; Chen HJ
    Mol Nutr Food Res; 2008 Jun; 52(6):646-54. PubMed ID: 18537129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
    Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
    Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.